RENAL IMPAIRMENT
Clinical trials for RENAL IMPAIRMENT explained in plain language.
Never miss a new study
Get alerted when new RENAL IMPAIRMENT trials appear
Sign up with your email to follow new studies for RENAL IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure drug test halted early in small kidney study
Disease control TerminatedThis early-stage study aimed to see if a single dose of an experimental drug, AZD3427, could improve blood flow to the kidneys in people who have both heart failure and reduced kidney function. Researchers used special PET scans to measure blood flow in the kidneys before and aft…
Matched conditions: RENAL IMPAIRMENT
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 02, 2026 03:41 UTC
-
Kidney-Friendly insulin study halted early
Disease control TerminatedThis study aimed to compare the effectiveness and safety of two long-acting insulin products (Gla-300 and IDeg-100) in adults with type 2 diabetes and reduced kidney function who had never used insulin before. Participants were randomly assigned to receive one of the two insulins…
Matched conditions: RENAL IMPAIRMENT
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 02, 2026 03:41 UTC
-
Early Heart-Kidney drug trial halted
Disease control TerminatedThis early-stage study aimed to test the safety and effects of an experimental drug called AZD5462 when added to a standard heart failure medication (dapagliflozin). It involved a small group of people who had both heart failure and moderate kidney impairment. The study was termi…
Matched conditions: RENAL IMPAIRMENT
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC